A previous study reported a lower percentage of EpCAM-positive EVs released from another HGSOC cell line (~24 %, OVCAR-3), an endometrioid cell line (~18%, ES-2) and a clear cell carcinoma cell line (~15%, IGROV) detected by fluorescent-NTA [18,34]. This evidence concerns the gene EPCAM and clear cell adenocarcinoma.